Fulgent Genetics Inc reports results for the quarter ended in December - Earnings Summary

Fulgent Genetics

24/02/2022 04:32

* Fulgent Genetics Inc  FLGT.OQ  reported quarterly adjusted
earnings of $3.34​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was
for earnings of $2.61 per share.
    * Revenue fell 14.7% to $251.67 million from a year ago; 
analysts
expected $191.10 million. 
    * Fulgent Genetics Inc's reported EPS for the quarter was
$3.34​.
    * The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Fulgent Genetics Inc shares had fallen by 38.1% this
quarter.
    * The company reported quarterly net income of $104.34
million.
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $102.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 24 at 04:32 a.m.
 ​All figures in US dollars unless otherwise stated